Current Pharmaceutical Design

Editor-in-Chief

Alessandro Antonelli
(12,288 citations)
Laboratory of Primary Human Cells
University of Pisa
Pisa
(Italy)

Executive Editor

Atta-ur-Rahman, FRS
(32052 citations)
Honorary Life Fellow
Kings College
University of Cambridge
Cambridge
(UK)
Biography

Nobel Laureate on Editorial Board

Andrew V. Schally
(USA)

Personal Subscription
Become EABM
Become Reviewer
Call for Editor

Articles Ahead of Print

Nanoparticles in Gastric Cancer Management

Alexandra V. Avgustinovich, Olga V. Bakina*, Sergey G. Afanas’ev, Olga V. Cheremisina, Liudmila V. Spirina, Alexey Yu. Dobrodeev, Michail Buldakov and Evgeny L. Choynzonov

Strategies for Preparing Different Types of Lipid Polymer Hybrid Nanoparticles in Targeted Tumor Therapy

Yong Zhuang, Yiye Zhao, Bingyue Wang, Qi Wang, Tiange Cai and Yu Cai*

Traditional Chinese Medicine Network Pharmacology in Cardiovascular Precision Medicine

Li Gao*, Min Cao, Jia-qi Li, Xue-mei Qin and Jian-song Fang

Therapeutic Management of COVID-19 Patients: Clinical Manifestation and Limitations

Urooj Fatima, Syed Saif Abbas Rizvi, Neha Raina, Saher Fatima, Safikur Rahman, Mohammad Amjad Kamal and Md. Imtaiyaz Hassan*

Histone Deacetylase Inhibitors and Papillary Thyroid Cancer

Eleftherios Spartalis*, Konstantinos Kotrotsios*, Dimosthenis Chrysikos, Michael Spartalis, Stavroula A. Paschou, Dimitrios Schizas, Konstantinos Tsamakis, Dimitrios Dimitroulis, Theodore Troupis and Nikolaos Nikiteas

Suppression of Spermatogenesis by Exogenous Testosterone

Ferdinando Fusco*, Paolo Verze, Marco Capece and Luigi Napolitano

Neuroprotective Effects of Ellagic Acid in Alzheimer's Disease: Focus on Underlying Molecular Mechanisms of Therapeutic Potential

Nimra Javaid, Muhammad Ajmal Shah*, Azhar Rasul, Zunera Chauhdary, Uzma Saleem, Haroon Khan, Nazir Ahmed, Md. Sahab Uddin, Bijo Mathew, Tapan Behl and Renald Blundell

GnRH in the treatment of Hypogonadotropic Hypogonadism

Carlo Bettocchi*, Marco Rinaldi and Francesco Sebastiani

Natural Products: A Rich Source of Antiviral Drug Lead Candidates for the Management of COVID-19

Yasanandana Supunsiri Wijayasinghe, Pravin Bhansali, Ronald E. Viola, Mohammad A. Kamal and Nitesh Kumar Poddar*